191 related articles for article (PubMed ID: 16905156)
1. Heterozygous individuals bearing a founder mutation in the XPA DNA repair gene comprise nearly 1% of the Japanese population.
Hirai Y; Kodama Y; Moriwaki S; Noda A; Cullings HM; Macphee DG; Kodama K; Mabuchi K; Kraemer KH; Land CE; Nakamura N
Mutat Res; 2006 Oct; 601(1-2):171-8. PubMed ID: 16905156
[TBL] [Abstract][Full Text] [Related]
2. Increased risk of skin cancer in Japanese heterozygotes of xeroderma pigmentosum group A.
Hirai Y; Noda A; Kodama Y; Cordova KA; Cullings HM; Yonehara S; Fujihara M; Moriwaki SI; Nishigori C; Mabuchi K; Kraemer KH; Nakamura N
J Hum Genet; 2018 Nov; 63(11):1181-1184. PubMed ID: 30089811
[TBL] [Abstract][Full Text] [Related]
3. Genotype-phenotype correlation of xeroderma pigmentosum in a Chinese Han population.
Sun Z; Zhang J; Guo Y; Ni C; Liang J; Cheng R; Li M; Yao Z
Br J Dermatol; 2015 Apr; 172(4):1096-102. PubMed ID: 25256075
[TBL] [Abstract][Full Text] [Related]
4. A prevalent mutation with founder effect in xeroderma pigmentosum group C from north Africa.
Soufir N; Ged C; Bourillon A; Austerlitz F; Chemin C; Stary A; Armier J; Pham D; Khadir K; Roume J; Hadj-Rabia S; Bouadjar B; Taieb A; de Verneuil H; Benchiki H; Grandchamp B; Sarasin A
J Invest Dermatol; 2010 Jun; 130(6):1537-42. PubMed ID: 20054342
[TBL] [Abstract][Full Text] [Related]
5. Genetic homogeneity of mutational spectrum of group-A xeroderma pigmentosum in Tunisian patients.
Messaoud O; Ben Rekaya M; Cherif W; Talmoudi F; Boussen H; Mokhtar I; Boubaker S; Amouri A; Abdelhak S; Zghal M
Int J Dermatol; 2010 May; 49(5):544-8. PubMed ID: 20534089
[TBL] [Abstract][Full Text] [Related]
6. Quantitative analysis of brain atrophy in patients with xeroderma pigmentosum group A carrying the founder mutation in Japan.
Ueda T; Kanda F; Nishiyama M; Nishigori C; Toda T
J Neurol Sci; 2017 Oct; 381():103-106. PubMed ID: 28991657
[TBL] [Abstract][Full Text] [Related]
7. Diagnosis of Xeroderma Pigmentosum Groups A and C by Detection of Two Prevalent Mutations in West Algerian Population: A Rapid Genotyping Tool for the Frequent XPC Mutation c.1643_1644delTG.
Bensenouci S; Louhibi L; De Verneuil H; Mahmoudi K; Saidi-Mehtar N
Biomed Res Int; 2016; 2016():2180946. PubMed ID: 27413738
[TBL] [Abstract][Full Text] [Related]
8. Mutational spectrum of Xeroderma pigmentosum group A in Egyptian patients.
Amr K; Messaoud O; El Darouti M; Abdelhak S; El-Kamah G
Gene; 2014 Jan; 533(1):52-6. PubMed ID: 24135642
[TBL] [Abstract][Full Text] [Related]
9. Genetic investigation of XPA gene: high frequency of the c.682C>T mutation in Moroccan XP patients with moderate clinical profile.
Kindil Z; Senhaji MA; Bakhchane A; Charoute H; Chihab S; Nadifi S; Barakat A
BMC Res Notes; 2017 Dec; 10(1):704. PubMed ID: 29208038
[TBL] [Abstract][Full Text] [Related]
10. Prenatal diagnosis of xeroderma pigmentosum group A in Japan.
Moriwaki S; Yamashita Y; Nakamura S; Fujita D; Kohyama J; Takigawa M; Ohmichi M
J Dermatol; 2012 Jun; 39(6):516-9. PubMed ID: 22168765
[TBL] [Abstract][Full Text] [Related]
11. Clinical and genetic characteristics of xeroderma pigmentosum in Nepal.
Espi P; Parajuli S; Benfodda M; Lebre AS; Paudel U; Grange A; Grybek V; Grange T; Soufir N; Grange F
J Eur Acad Dermatol Venereol; 2018 May; 32(5):832-839. PubMed ID: 29178624
[TBL] [Abstract][Full Text] [Related]
12. Xeroderma pigmentosum: low prevalence of germline XPA mutations in a Brazilian XP population.
Santiago KM; França de Nóbrega A; Rocha RM; Rogatto SR; Achatz MI
Int J Mol Sci; 2015 Apr; 16(4):8988-96. PubMed ID: 25913378
[TBL] [Abstract][Full Text] [Related]
13. An XPA gene splicing mutation resulting in trace protein expression in an elderly patient with xeroderma pigmentosum group A without neurological abnormalities.
Takahashi Y; Endo Y; Kusaka-Kikushima A; Nakamaura S; Nakazawa Y; Ogi T; Uryu M; Tsuji G; Furue M; Moriwaki S
Br J Dermatol; 2017 Jul; 177(1):253-257. PubMed ID: 27603812
[TBL] [Abstract][Full Text] [Related]
14. XPA gene mutations resulting in subtle truncation of protein in xeroderma pigmentosum group A patients with mild skin symptoms.
Takahashi Y; Endo Y; Sugiyama Y; Inoue S; Iijima M; Tomita Y; Kuru S; Takigawa M; Moriwaki S
J Invest Dermatol; 2010 Oct; 130(10):2481-8. PubMed ID: 20574439
[TBL] [Abstract][Full Text] [Related]
15. Ancient origin of a Japanese xeroderma pigmentosum founder mutation.
Imoto K; Nadem C; Moriwaki S; Nishigori C; Oh KS; Khan SG; Goldstein AM; Kraemer KH
J Dermatol Sci; 2013 Feb; 69(2):175-6. PubMed ID: 23194742
[No Abstract] [Full Text] [Related]
16. Four types of possible founder mutations are responsible for 87% of Japanese patients with Xeroderma pigmentosum variant type.
Masaki T; Ono R; Tanioka M; Funasaka Y; Nagano T; Moriwaki S; Nishigori C
J Dermatol Sci; 2008 Nov; 52(2):144-8. PubMed ID: 18703314
[No Abstract] [Full Text] [Related]
17. Carrier frequency of the recurrent mutation c.1643_1644delTG in the XPC gene and birth prevalence of the xeroderma pigmentosum in Morocco.
Doubaj Y; Laarabi FZ; Elalaoui SC; Barkat A; Sefiani A
J Dermatol; 2012 Apr; 39(4):382-4. PubMed ID: 22211393
[TBL] [Abstract][Full Text] [Related]
18. Founder mutations in xeroderma pigmentosum.
Tamura D; DiGiovanna JJ; Kraemer KH
J Invest Dermatol; 2010 Jun; 130(6):1491-3. PubMed ID: 20463673
[TBL] [Abstract][Full Text] [Related]
19. High prevalence of the point mutation in exon 6 of the xeroderma pigmentosum group A-complementing (XPAC) gene in xeroderma pigmentosum group A patients in Tunisia.
Nishigori C; Zghal M; Yagi T; Imamura S; Komoun MR; Takebe H
Am J Hum Genet; 1993 Nov; 53(5):1001-6. PubMed ID: 8105686
[TBL] [Abstract][Full Text] [Related]
20. Correlation of the clinical manifestations and gene mutations of Japanese xeroderma pigmentosum group A patients.
Kondoh M; Ueda M; Ichihashi M
Br J Dermatol; 1995 Oct; 133(4):579-85. PubMed ID: 7577588
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
